This bill amends Section 37-2711 of the Idaho Code to classify the drugs Mifepristone and Misoprostol as Schedule IV controlled substances. The inclusion of these drugs in Schedule IV indicates that they are recognized as having a lower potential for abuse compared to substances in higher schedules, while still being regulated due to their medical use. The bill also removes Pentazocine from the list of substances in this section, effectively updating the classification of controlled substances in Idaho.

Additionally, the bill declares an emergency, stating that it will take effect on July 1, 2025. This expedited timeline suggests a pressing need for the regulation of Mifepristone and Misoprostol as controlled substances, reflecting ongoing discussions about their use and potential risks. The legislative action aims to ensure that these medications are appropriately monitored while still being accessible for legitimate medical purposes.

Statutes affected:
Bill Text: 37-2711